{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:04Z","timestamp":1792787704215,"version":"4.5.0"},"reference-count":75,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"CENTER FOR NEUROLOGICAL DISORDER,"},{"name":"Regional MS Center"},{"name":"Pamela Harvey, PhD, Acumen Medical Communications"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Therapeutic plasma exchange (PLEX) is a powerful and fast-acting immunomodulating therapy that is underutilized for autoimmune neurological disorders. Here, we present the largest collection of real-world experiences with PLEX procedures to date in the treatment of autoimmune neurological conditions, supporting its safety and clinical benefits with patient cases and corresponding patient videos. Our collective real-world experience with PLEX spans over 67\u2009years, 90,210 procedures, and includes nine double-blind randomized controlled and unblinded studies serving as principal investigators. Case histories and videos of our patients demonstrate when and how PLEX should be used, identify barriers to using PLEX, and ways to overcome these barriers. Specific protocol details are shared of how to treat an acute or chronic phase of a disease. If used appropriately and early in the disease course for both acute and chronic progressive phases, PLEX can safely change the trajectory of many autoimmune neurological disorders in both outpatient and inpatient settings.<\/jats:p>","DOI":"10.1177\/17562864251401510","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T18:11:48Z","timestamp":1766599908000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 procedures"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6477-181X","authenticated-orcid":false,"given":"Bhupendra O.","family":"Khatri","sequence":"first","affiliation":[{"name":"Ascension Health Wisconsin, Center for Neurological Disorders, Milwaukee, WI, USA"},{"name":"The Regional MS Center &amp; The Center for Neurological Disorders, 3237 S. 16th Street, Milwaukee, WI 53215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Berkovich","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Raval","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dukic","sequence":"additional","affiliation":[{"name":"Ascension Health Wisconsin, Center for Neurological Disorders, Milwaukee, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sershon","sequence":"additional","affiliation":[{"name":"Ascension Health Wisconsin, Center for Neurological Disorders, Milwaukee, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100046564"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1143"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000341766.59028.9d"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21215"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.4172\/2376-0389.1000102"},{"issue":"8","key":"e_1_3_4_7_2","article-title":"The Guillain-Barre syndrome Study Group","volume":"35","author":"Plasmapheresis and acute Guillain-Barre syndrome","year":"1985","unstructured":"Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology 1985; 35(8): 1096\u2013104.","journal-title":"Neurology"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(90)90073-A"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1984.04050180056018"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"e_1_3_4_11_2","article-title":"Relapse management in multiple sclerosis: corticosteroids remain the linchpin of therapies","author":"Thompson CA","year":"2024","unstructured":"Thompson CA, Jayagopal LA, Zabad RK. Relapse management in multiple sclerosis: corticosteroids remain the linchpin of therapies. Pract Neurol 2024; Jan\/Feb: 12\u201330.","journal-title":"Pract Neurol"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23356-w"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282x20180078"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-024-02606-w"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318207b1f6"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01352.x"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.3.312"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.3.409"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.2920100402"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93389-Q"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.07.009"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-021-00677-1"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25927"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06197-3"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105009"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1380654"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113177"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy174"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120459"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054693"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.06.008"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420975642"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.34"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134583"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-005-2019-1"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/787630"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197711242972102"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.11.007"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1055"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211057314"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-021-10004-9"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2019-002336"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40080896.x"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.10060"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21643"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092874"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.14223"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2023.103831"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12629"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00266-5"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2001.00386.x"},{"key":"e_1_3_4_54_2","first-page":"318","article-title":"Plasmapheresis in multiple sclerosis: Correlation of clinical improvement with increased suppressor cell activity in peripheral blood","volume":"105","author":"Khatri BO","year":"1980","unstructured":"Khatri BO, McQuillen MP, Koethe SM, et al. Plasmapheresis in multiple sclerosis: Correlation of clinical improvement with increased suppressor cell activity in peripheral blood. Trans Am Neurol Assoc 1980; 105: 318\u2013320.","journal-title":"Trans Am Neurol Assoc"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20342"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-0502(01)00079-9"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2153534"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04547.x"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1212868"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285608093888"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.930"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2020.10.017"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316286"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102709"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.04.021"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119840195"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076552"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00717"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01117-3"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103421"},{"issue":"8","key":"e_1_3_4_71_2","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"2015","author":"Mehndiratta MM","year":"2015","unstructured":"Mehndiratta MM, Hughes RA, Pritchard J. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;2015(8):CD003906.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0401-7"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2016.1214823"},{"issue":"10","key":"e_1_3_4_74_2","article-title":"Evaluating the efficacy and cost-effectiveness of plasmapheresis and intravenous immunoglobulin in acute Guillain-Barre syndrome management in emergency departments","volume":"16","author":"Ullah W","year":"2024","unstructured":"Ullah W, Ali H, Muhammad Y, et al. Evaluating the efficacy and cost-effectiveness of plasmapheresis and intravenous immunoglobulin in acute Guillain-Barre syndrome management in emergency departments. Cureus 2024; 16(10): e72595.","journal-title":"Cureus"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08210-z"},{"issue":"3","key":"e_1_3_4_76_2","article-title":"Treatment efficacy of plasmapheresis versus intravenous immunoglobulin in Guillain-Barre syndrome management: a systematic review","volume":"16","author":"Savithri Nandeesha S","year":"2024","unstructured":"Savithri Nandeesha S, Kasagga A, Hawrami C, et al. Treatment efficacy of plasmapheresis versus intravenous immunoglobulin in Guillain-Barre syndrome management: a systematic review. Cureus 2024; 16(3): e57066.","journal-title":"Cureus"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251401510","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251401510","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251401510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:29:44Z","timestamp":1769362184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251401510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":75,"alternative-id":["10.1177\/17562864251401510"],"URL":"https:\/\/doi.org\/10.1177\/17562864251401510","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"17562864251401510"}}